Ekspomeda - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 135,628 | 607,993 | 671,387 | 439,777 | 261,680 | 1,776,863 | 3,685,363 | 1,221,510 |
| Profit before tax | - | 58,101 | 2,274 | 9,936 | 100,607 | 72,114 | 174,050 | 76,435 |
| Net profit | 1,259 | 49,079 | 1,116 | 4,162 | 95,569 | 61,198 | 148,055 | 63,154 |
| Equity | 12,198 | 61,278 | 62,394 | 66,556 | 162,125 | 223,323 | 371,378 | 434,532 |
| Liabilities | 21,165 | 220,920 | 166,901 | 53,318 | 8,718 | 375,501 | 227,569 | 185,760 |
| Non-current assets | 8,771 | 23,572 | 52,585 | 1,066 | 85,324 | 391,608 | 136,821 | 94,353 |
| Current assets | 29,612 | 253,799 | 127,128 | 118,808 | 85,519 | 205,864 | 461,569 | 521,349 |
| Total assets | 38,383 | 277,371 | 179,713 | 119,874 | 170,843 | 597,472 | 598,390 | 615,702 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 26,097 | - | - |
| Social insurance contributions | - | - | - | - | - | 51,202 | 41,312 | 36,113 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +2.2% | +348.3% | +10.4% | -34.5% | -40.5% | +579.0% | +107.4% | -66.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 3.3% | 17.7% | 0.6% | 3.5% | 55.9% | 10.2% | 24.7% | 10.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 10.3% | 80.1% | 1.8% | 6.3% | 58.9% | 27.4% | 39.9% | 14.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.9% | 8.1% | 0.2% | 0.9% | 36.5% | 3.4% | 4.0% | 5.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | 9.6% | 0.3% | 2.3% | 38.4% | 4.1% | 4.7% | 6.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.7 | 3.6 | 2.7 | 0.8 | 0.1 | 1.7 | 0.6 | 0.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 8,477 | 45,600 | 53,004 | 34,492 | 30,194 | 81,383 | 245,691 | 101,793 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Ekspomeda - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-06-16 | 2026-06-18 | 4904.95 |
| 2025-12-16 | 2025-12-16 | 3130.52 |
| 2025-10-16 | 2025-10-16 | 3224.54 |
| 2025-03-18 | 2025-03-19 | 1967.13 |
| 2025-02-10 | 2025-02-10 | 60.73 |
| 2025-01-16 | 2025-01-30 | 60.73 |
| 2023-10-24 | 2023-10-30 | 9.67 |
| 2023-10-17 | 2023-10-22 | 3666.03 |
| 2023-09-18 | 2023-09-21 | 5709.46 |
| 2023-08-17 | 2023-08-17 | 4224.04 |
| 2023-06-16 | 2023-06-19 | 85.49 |
| 2023-05-16 | 2023-05-18 | 3886.29 |
| 2022-07-18 | 2022-07-18 | 711.58 |
| 2022-02-17 | 2022-02-24 | 922.57 |
| 2021-12-01 | 2021-12-01 | 634.75 |
| 2021-11-30 | 2021-11-30 | 1115.47 |
| 2021-11-16 | 2021-11-29 | 1203.00 |
| 2021-11-09 | 2021-11-14 | 5.22 |
| 2021-11-05 | 2021-11-08 | 1095.22 |
| 2021-10-18 | 2021-11-04 | 1078.16 |
| 2021-09-16 | 2021-09-20 | 1533.81 |
Ekspomeda - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-12-17 | 2025-12-17 | 146.71 |
| 2025-08-21 | 2025-08-25 | 2.78 |
| 2025-08-19 | 2025-08-20 | 1122.4 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Ekspomeda, UAB (code 304177200) is a Private Limited Liability Company operating in floor and wall covering. In the latest financial year, 2025, revenue was €1.22M, down 66.9% year on year and 31.2% below the 2023 level after a strong peak in 2024 at €3.69M. Net profit in 2025 amounted to €63.2K, compared with €148.1K in 2024 and €61.2K in 2023, while the profit margin improved to 5.2% from 4.0% and 3.4%. The balance sheet remained stable, with total assets of €615.7K in 2025 versus €598.4K in 2024 and €597.5K in 2023. Equity increased to €434.5K, liabilities declined to €185.8K, and the equity ratio stood at 70.6%. Return on equity was 14.5%, return on assets 10.3%, debt-to-equity 0.43, and asset turnover 1.98x. Revenue per employee was €101.8K and profit per employee €5.3K. Overall, 2025 was a lower-sales year, but the company maintained profitability and a comparatively strong capital structure.